Mounjaro is a treatment for Type 2 diabetes that activates GIP and GLP-1 pathways to help regulate blood sugar. It’s part of ...
Eli Lilly & Co (LLY – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Mohit ...
Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...
The success of GLP-1R-targeting drugs highlights their viability as a treatment approach. Currently, there are four ...
Eli Lilly and Company chief corporate brand officer Lina Polimeni described the new format as a “big evolution” in the ...
New Barcelona site to help drive global expansion of QIAstat-Dx as QIAGEN expands local presence with multi-year investment ...
CFO to depart at year-end in move that comes after CEO exited in September WW International Inc., the company known as ...
Amgen's MariTide shows promising weight loss results in Phase II for type 2 diabetes. Find out why AMGN stock remains as a strong buy for long-term investors.
11hon MSNOpinion
Whoever says the Food and Drug Administration is too cozy with Big Pharma isn’t paying attention to the bonanza of new ...
Erste Group downgraded Eli Lilly (LLY) to Hold from Buy.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback